Added to YB: 2024-07-08
Pitch date: 2024-07-08
BCAB:US [bullish]
BioAtla, Inc.
-98.02%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
Market Cap
$2.1M
Pitch Price
$65.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.22
P/E
-0.06
EV/Sales
0.76
Sector
Biotechnology
Category
N/A
Show full summary:
BioAtla, Inc. BCAB:US
A summary for this pitch has not been created yet.
Read full article (0 min)